TISDALE MICHAEL JOHN has a total of 13 patent applications. Its first patent ever was published in 1989. It filed its patents most often in United States, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are SOPHERION THERAPEUTICS INC, ARPI MATOSSIAN ROGERS and MOLECULAR LOGIX INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | Canada | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | United Kingdom | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 | |
#6 | Australia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Analysing materials | |
#5 | Foods |
# | Name | Total Patents |
---|---|---|
#1 | Tisdale Michael John | 13 |
#2 | Todorov Penio Todorov | 4 |
#3 | Beck Susan Anne | 4 |
#4 | Eley Helen Laura | 2 |
#5 | Todorov Penio | 2 |
#6 | Wyke Stacey Marie | 2 |
#7 | Miller Kevin Burke | 2 |
#8 | Greenberg Norman Alan | 1 |
#9 | Russell Steve Thomas | 1 |
Publication | Filing date | Title |
---|---|---|
WO9962939A2 | Glycoproteins having lipid mobilising properties and therapeutic applications thereof | |
CA2052577A1 | Therapeutic uses of eicosapentaenoic acid | |
GB9006256D0 | Eicosapentaenoic acid | |
GB8906371D0 | Lipolytic material associated with cachexia inducing tumours, preparations,production and uses thereof. |